Concepedia

Kris Vaddi

KV

Statistics

Publications

65

Citations

9.7K

H-Index

38

Active since

1999

Affiliations

Incyte (United States)(Current)

The University of Texas MD Anderson Cancer Center

Mayo Clinic in Arizona

Cornell University

Experimental Station

Kris Vaddi is an author at Incyte (United States) specializing in medicine, immunology, and pharmacology.

ORCID

Top concepts

Publications per year

1999–2023

65

Publications

65

A Double-Blind, Placebo-Controlled Trial of Ruxolitinib for Myelofibrosis

Srđan Verstovšek, Ruben A. Mesa, Jason Gotlib et al. · New England Journal of Medicine · 2012 · 2K citations · Full text

CCR2 modulates inflammatory and metabolic effects of high-fat feeding

Stuart P. Weisberg, Deborah Hunter, Reid Huber et al. · Journal of Clinical Investigation · 2005 · 1.5K citations · Full text

, , +16

Safety and Efficacy of INCB018424, a JAK1 and JAK2 Inhibitor, in Myelofibrosis

Srđan Verstovšek, Hagop M. Kantarjian, Ruben A. Mesa et al. · New England Journal of Medicine · 2010 · 1.2K citations · Full text

Preclinical characterization of the selective JAK1/2 inhibitor INCB018424: therapeutic implications for the treatment of myeloproliferative neoplasms

Alfonso Quintás‐Cardama, Kris Vaddi, Phillip Liu et al. · Blood · 2010 · 813 citations

Selective Inhibition of JAK1 and JAK2 Is Efficacious in Rodent Models of Arthritis: Preclinical Characterization of INCB028050

Jordan S. Fridman, Peggy Scherle, Robert J. Collins et al. · The Journal of Immunology · 2010 · 440 citations · Full text

, , +21

1–5 of 65